Commercial interests, transparency, and independence: a call for submissions

Ray Moynihan, Helen Macdonald, Carl Heneghan, Lisa Bero, Fiona Godlee

Research output: Contribution to journalEditorialResearch

Abstract

[Extract] Help the move towards independence from commercial interests

A decade ago the US Institute of Medicine (IOM) issued a landmark report on conflicts of interest in research, medical education, and practice.1 Highlighting benefits of collaborations between physicians, researchers, and companies to develop new products that can improve health, the report also raised substantial concerns that extensive financial ties could unduly influence professional judgments. It concluded these financial conflicts of interest could jeopardise the integrity of science, the objectivity of education, the quality of care, and public trust in medicine. The report recommended more research on conflicts of interest, improvements in transparency, and greater independence from industry.

Today we announce plans for a stream of BMJ content to revisit these concerns and ask you to join us. A key aim is to identify and respond to commercial influences on health and healthcare, to understand under what circumstances involvement with industry is truly necessary. Where it is not necessary, we want to forge a new independence from those who make and sell products, to strengthen trust in how evidence is produced and disseminated, and to drive more rational and safer use of drugs, devices, diagnoses, and data in the public interest.
Original languageEnglish
Article numberl1706
JournalBMJ (Online)
Volume365
DOIs
Publication statusPublished - 16 Apr 2019

    Fingerprint

Cite this